Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL741

LAMOTRIGINE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1

Basic Information

ChEMBL ID CHEMBL741
Name LAMOTRIGINE
Phase Approved
Structure Type MOL
InChI Key PYZRQGJRPPTADH-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

BW 430C BW-430C Lamictal Lamictal cd Lamictal odt Lamictal xr Lamotrigina Lamotrigine NSC-759171
12
Targets
36
Activities
2
Assay Types
13
PK Parameters
20
Publications
9
Known Names
20
Indications
1
Mechanisms

Molecular Properties

256.1
MW (Da)
2.01
ALogP
5
HBA
2
HBD
90.7
PSA (Ų)
0.81
QED
0
Ro5 Violations
1
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1994
Availability Prescription
Chirality Achiral

Routes of Administration

Oral

Flags

Black Box Warning Natural Product
USAN Stem -trigine
USAN Year 1985

Extended Properties

Molecular Formula C9H7Cl2N5
MW 256.10
Aromatic Rings 2
Heavy Atoms 16
NP-Likeness -1.11

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Sodium channel alpha subunit blocker BLOCKER Sodium channel alpha subunit

Indications

Bipolar Disorder Bipolar Disorder Depressive Disorder Depressive Disorder Epilepsies, Partial Epilepsy Epilepsy, Tonic-Clonic Epilepsy, Tonic-Clonic Lennox Gastaut Syndrome Seizures Anxiety Dementia Epilepsy, Absence Feeding and Eating Disorders Mood Disorders Obesity Pain Peripheral Nervous System Diseases Schizophrenia Alcoholism

ATC Classification

N03AX09
lamotrigine
Level 1: NERVOUS SYSTEM
Level 2: ANTIEPILEPTICS

Drug Warnings

Black Box Warning
dermatological toxicity
Country: United States

Activity Summary

IC50 33 meas. best 5.58
Ki 3 meas. best 4.82

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.58 4.625 2600.0 8
Sodium channel protein type 2 subunit alpha
CHEMBL4187
IC50 5.0 4.885 10000.0 2
Dihydrofolate reductase
CHEMBL1809
Ki 4.82 4.82 15240.0 1
Sodium channel protein type 4 subunit alpha
CHEMBL2072
Ki 4.77 4.77 17000.0 1
Sodium channel protein type 9 subunit alpha
CHEMBL4296
IC50 4.77 4.77 17000.0 1
Sodium channel protein type 3 subunit alpha
CHEMBL5163
IC50 4.77 4.77 17000.0 1
Sodium channel protein type 10 subunit alpha
CHEMBL4017
IC50 4.6 4.6 25000.0 1
Nucleic Acid
CHEMBL345
Ki 4.54 4.54 29200.0 1
Sodium channel alpha subunits; brain (Types I, II, III)
CHEMBL2095171
IC50 4.51 4.51 31000.0 1
Sodium channel protein type 2 subunit alpha
CHEMBL3399
IC50 4.46 4.46 35000.0 2
Sodium channel protein type 5 subunit alpha
CHEMBL1980
IC50 4.4 4.2033 39810.7 3
Sodium channel protein type 10 subunit alpha
CHEMBL5451
IC50 4.02 4.015 96000.0 2

Pharmacokinetic Data

Parameter Value Units Species
CL 1.0 mL.min-1.kg-1 Rattus norvegicus
CL 0.6 mL.min-1.kg-1 Homo sapiens
CL 0.6 mL.min-1.kg-1 Homo sapiens
CL 1.4 mL.min-1.kg-1 Mus musculus
CL 1.4 uL.min-1.(10^6cells)-1 Homo sapiens
Cmax 13666.54 nM Rattus norvegicus
F 80.0 % Homo sapiens
F 79.0 % Rattus norvegicus
Fu 0.51 - Rattus norvegicus
Fu 0.21 - Rattus norvegicus
Fu 0.45 - Homo sapiens
T1/2 10.1 hr Mus musculus
Vd 4.6 L.kg-1 Rattus norvegicus

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 2600.0 nM 5.58 Displacement of [3H]BW202W92 from voltage-gated sodium channel in Wistar rat for... 19341281
Unchecked IC50 = 8100.0 nM 5.09 Inhibition of human aquaporin 4 M23 isoform expressed in Xenopus laevis oocytes 18178093
Sodium channel protein type 2 subunit alpha IC50 = 10000.0 nM 5.0 Inhibition of human recombinant Nav1.2 channel expressed in HEK293 cells by whol... 18501613
Dihydrofolate reductase Ki = 15240.0 nM 4.82 Inhibition of Escherichia coli DHFR assessed as NADP formation by quadratic Morr... 26414808
Sodium channel protein type 2 subunit alpha IC50 = 17000.0 nM 4.77 Inhibition of human Nav1.2 expressed in SHSY5Y cells assessed as reduction in bl... 26101568
Sodium channel protein type 3 subunit alpha IC50 = 17000.0 nM 4.77 Inhibition of human Nav1.3 expressed in SHSY5Y cells assessed as reduction in bl... 26101568
Sodium channel protein type 9 subunit alpha IC50 = 17000.0 nM 4.77 Inhibition of human Nav1.7 expressed in SHSY5Y cells assessed as reduction in bl... 26101568
Sodium channel protein type 4 subunit alpha Ki = 17000.0 nM 4.77 Affinity for inactive human SkM1 sodium channel expressed in HEK293 cells 14998340
Unchecked IC50 = 21000.0 nM 4.68 Inhibition of veratridine-induced guanidine flux in cardiac voltage-gated sodium... 11170622
Sodium channel protein type 10 subunit alpha IC50 = 25000.0 nM 4.6 Blockade of Nav1.8 channel in rat dorsal root ganglion neurons assessed as inhib... 18501613
Unchecked IC50 = 25820.0 nM 4.59 PUBCHEM_BIOASSAY: A counter screen for small molecule screen for inhibitors of t... -
Nucleic Acid Ki = 29200.0 nM 4.54 Dissociation constant for binding to inactivated state of rat brain NaIIa (rNav1... 15293999
Sodium channel alpha subunits; brain (Types I, II, III) IC50 = 31000.0 nM 4.51 Concentration required to inhibit [3H]BTX binding to Sodium channel of rat brain 15177465
Unchecked IC50 = 32987.0 nM 4.48 PUBCHEM_BIOASSAY: A screen for inhibitors of the PhoP region in Salmonella Typhi... -
Sodium channel protein type 2 subunit alpha IC50 = 35000.0 nM 4.46 Inhibition of rat Nav1.2 expressed in CHL1610 cells at -67 to -107 mV after 2 to... 24205976
Sodium channel protein type 2 subunit alpha IC50 = 35000.0 nM 4.46 Inhibition of rat Nav1.2 channel expressed in chinese hamster CHL1610 cells at p... 19388676
Sodium channel protein type 5 subunit alpha IC50 = 39810.72 nM 4.4 Inhibition of fast sodium current (INa) in HEK293 cells transfected with human N... 25087753
Unchecked IC50 = 60490.0 nM 4.22 PUBCHEM_BIOASSAY: A Counter Screen to identiry small molecule screen for inhibit... -
Sodium channel protein type 5 subunit alpha IC50 = 62000.0 nM 4.21 Inhibition of human recombinant Nav1.5 channel expressed in HEK293 cells by whol... 18501613
Unchecked IC50 = 66350.0 nM 4.18 PUBCHEM_BIOASSAY: A screen for inhibitors of the PhoP region in Salmonella Typhi... -

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL3885881 Rattus norvegicus 332
- 10.5281/zenodo.13943903 ADMET 89
31158845 10.1038/s41586-019-1291-3 ADMET 58
17451232 10.1021/jm061431g Rattus norvegicus 40
16472241 10.2174/1570163043334794 Hepatotoxicity 18
22194678 10.1371/journal.pcbi.1002310 Hepatotoxicity 14
15646539 10.1016/s0399-8320(04)95062-2 Unchecked 11
18403060 10.1016/j.ejmech.2008.01.036 Mus musculus 9
15646539 10.1016/s0399-8320(04)95062-2 NON-PROTEIN TARGET 8
18501613 10.1016/j.bmc.2008.05.003 Rattus norvegicus 8
18572411 10.1016/j.bmc.2008.06.005 Aquaporin-4 7
20070106 10.1021/jm901371v Homo sapiens 7
29681486 10.1016/j.bmc.2018.04.023 Mus musculus 6
9484507 10.1021/jm970599m Mus musculus 5
- 10.1007/s00044-013-0843-6 Mus musculus 4
26414808 10.1016/j.ejmech.2015.08.021 Dihydrofolate reductase 4
19341281 10.1021/jm801180p Sodium channel protein type 2 subunit alpha 4
19764786 10.1021/jm901036q Plasma 4
37468498 10.1038/s41467-023-40064-9 Alpha-1A adrenergic receptor 4
26690914 10.1016/j.bmc.2015.11.021 Mus musculus 4

Data from ChEMBL 36 via Core Engine